SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-23-059294
Filing Date
2023-12-20
Accepted
2023-12-20 10:33:33
Documents
1
Period of Report
2022-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3655
  Complete submission text file 0001209191-23-059294.txt   5392
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503
Business Address
Lim Seah H. (Reporting) CIK: 0001949484 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-35527 | Film No.: 231500081